Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
7.98
-0.30 (-3.62%)
At close: Mar 9, 2026, 4:00 PM EDT
8.00
+0.02 (0.25%)
After-hours: Mar 9, 2026, 4:29 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $18.66 million as of March 9, 2026. Its market cap has decreased by -45.55% in one year.
Market Cap
18.66M
Enterprise Value
15.50M
1-Year Change
-45.55%
Ranking
Category
Stock Price
$7.98
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $18.66M, a decrease of -67.93%. That is a compound annual growth rate of -30.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 19.36M | 22.12% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |